Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation Sequencing

Clinical trial NCT02861651 · COMPLETED

Trial details

NCT number: NCT02861651
Sponsor: Institut Paoli-Calmettes
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Myeloid Leukemia

Start date: 2014-03-01
Primary completion: 2015-07-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.